Peter Rothschild is Group President and founder of BioGaia together with Jan Annwall. Peter is an experienced entrepreneur and successful businessman. He guided BioGaia’s establishment and successful development as Managing Director of BioGaia for 19 years. Peter is also Chairman of the board of directors of several companies including TwoPac AB and MetaboGen AB.
Jan Annwall is the former Executive Vice President and CFO of BioGaia. Jan founded BioGaia together with Peter Rothschild. He has extensive experience in finances and is currently CEO of Annwall & Rothschild Investments AB.
M.D., Ph.D., D.D.S., Assoc. Prof.
Anders Ekblom has extensive experience as an executive and leader with broad business knowledge from senior roles in the biopharmaceutical industry. During 19 years at AstraZeneca, Anders was a member of global executive teams holding different senior roles including Executive Vice President Global Medicines Development, and CEO AstraZeneca AB Sweden. He is currently Chairman of the Board at the Karolinska University Hospital.
Margareta Hagman is working as CFO and Executive Vice President at BioGaia AB. Margareta has been at BioGaia since 1996 and in current position since 2010 and has broad experience in accounting, finance and investor relations.